Zeldox® belongs to second generation of antipsychotics, which is used for controlling and improving symptoms of schizophrenia1,2. Zeldox® mainly targets dopamine and serotonin neurotransmission1. Zeldox® is less likely to affect glucose and lipid metabolism, with rare chance in development of diabetes mellitus, and is weight-neutral2,3.
- Zeldox® (ziprasidone HCl) Prescribing Information. Pfizer Corporation Hong Kong Limited: version November 2018.
- Greenberg WM & Citrome L. Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials. CNS Drug Reviews 2007; 13(2):137-177.
- Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med (2005) 353;12:1209-1223.